194 related articles for article (PubMed ID: 33799405)
1. Engineered
Esposito G; Pesce M; Seguella L; Lu J; Corpetti C; Del Re A; De Palma FDE; Esposito G; Sanseverino W; Sarnelli G
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799405
[TBL] [Abstract][Full Text] [Related]
2. A Palmitoylethanolamide Producing
Esposito G; Corpetti C; Pesce M; Seguella L; Annunziata G; Del Re A; Vincenzi M; Lattanzi R; Lu J; Sanseverino W; Sarnelli G
Front Pharmacol; 2021; 12():639728. PubMed ID: 33986673
[TBL] [Abstract][Full Text] [Related]
3. Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation.
Esposito G; Capoccia E; Turco F; Palumbo I; Lu J; Steardo A; Cuomo R; Sarnelli G; Steardo L
Gut; 2014 Aug; 63(8):1300-12. PubMed ID: 24082036
[TBL] [Abstract][Full Text] [Related]
4. Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner.
Sarnelli G; D'Alessandro A; Iuvone T; Capoccia E; Gigli S; Pesce M; Seguella L; Nobile N; Aprea G; Maione F; de Palma GD; Cuomo R; Steardo L; Esposito G
PLoS One; 2016; 11(5):e0156198. PubMed ID: 27219328
[TBL] [Abstract][Full Text] [Related]
5. Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.
Capasso R; Orlando P; Pagano E; Aveta T; Buono L; Borrelli F; Di Marzo V; Izzo AA
Br J Pharmacol; 2014 Sep; 171(17):4026-37. PubMed ID: 24818658
[TBL] [Abstract][Full Text] [Related]
6. A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation.
Esposito E; Impellizzeri D; Bruschetta G; Cordaro M; Siracusa R; Gugliandolo E; Crupi R; Cuzzocrea S
Eur J Pharmacol; 2016 Jul; 782():107-18. PubMed ID: 27095683
[TBL] [Abstract][Full Text] [Related]
7. N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.
Alhouayek M; Bottemanne P; Subramanian KV; Lambert DM; Makriyannis A; Cani PD; Muccioli GG
FASEB J; 2015 Feb; 29(2):650-61. PubMed ID: 25384424
[TBL] [Abstract][Full Text] [Related]
8. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.
Borrelli F; Romano B; Petrosino S; Pagano E; Capasso R; Coppola D; Battista G; Orlando P; Di Marzo V; Izzo AA
Br J Pharmacol; 2015 Jan; 172(1):142-58. PubMed ID: 25205418
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of Lactobacillus paracasei subsp. paracasei NTU 101 powder on dextran sulfate sodium-induced colitis in mice.
Chen CL; Hsu PY; Pan TM
J Food Drug Anal; 2019 Jan; 27(1):83-92. PubMed ID: 30648597
[TBL] [Abstract][Full Text] [Related]
10. A Glucuronic Acid-Palmitoylethanolamide Conjugate (GLUPEA) Is an Innovative Drug Delivery System and a Potential Bioregulator.
Manzo E; Schiano Moriello A; Tinto F; Verde R; Allarà M; De Petrocellis L; Pagano E; Izzo AA; Di Marzo V; Petrosino S
Cells; 2021 Feb; 10(2):. PubMed ID: 33672574
[TBL] [Abstract][Full Text] [Related]
11. Harnessing the anti-inflammatory potential of palmitoylethanolamide.
Alhouayek M; Muccioli GG
Drug Discov Today; 2014 Oct; 19(10):1632-9. PubMed ID: 24952959
[TBL] [Abstract][Full Text] [Related]
12. Lactobacillus paracasei R3 protects against dextran sulfate sodium (DSS)-induced colitis in mice via regulating Th17/Treg cell balance.
Huang J; Yang Z; Li Y; Chai X; Liang Y; Lin B; Ye Z; Zhang S; Che Z; Zhang H; Zhang X; Zhang Z; Chen T; Yang W; Zeng J
J Transl Med; 2021 Aug; 19(1):356. PubMed ID: 34407839
[TBL] [Abstract][Full Text] [Related]
13. Palmitoylethanolamide: A Natural Compound for Health Management.
Clayton P; Hill M; Bogoda N; Subah S; Venkatesh R
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069940
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of Lactobacillus paracasei N1115 on neonatal mice prevents the intestinal inflammation in adulthood.
Xun Y; Yan F; Zhu H; Feng L; Zhang D; Xue Y; He F; Wang S
Lett Appl Microbiol; 2022 Aug; 75(2):330-337. PubMed ID: 35485997
[TBL] [Abstract][Full Text] [Related]
15. Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis.
Petrosino S; Puigdemont A; Della Valle MF; Fusco M; Verde R; Allarà M; Aveta T; Orlando P; Di Marzo V
Vet J; 2016 Jan; 207():85-91. PubMed ID: 26639824
[TBL] [Abstract][Full Text] [Related]
16. The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats.
Impellizzeri D; Ahmad A; Bruschetta G; Di Paola R; Crupi R; Paterniti I; Esposito E; Cuzzocrea S
Eur J Pharmacol; 2015 Aug; 761():28-35. PubMed ID: 25934566
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon.
Couch DG; Tasker C; Theophilidou E; Lund JN; O'Sullivan SE
Clin Sci (Lond); 2017 Nov; 131(21):2611-2626. PubMed ID: 28954820
[TBL] [Abstract][Full Text] [Related]
18. GPA peptide enhances Nur77 expression in intestinal epithelial cells to exert a protective effect against DSS-induced colitis.
Deng Z; Zheng L; Xie X; Wei H; Peng J
FASEB J; 2020 Nov; 34(11):15364-15378. PubMed ID: 32978839
[TBL] [Abstract][Full Text] [Related]
19. Effect of N-palmitoylethanolamine-oxazoline on comorbid neuropsychiatric disturbance associated with inflammatory bowel disease.
Cordaro M; Scuto M; Siracusa R; D'amico R; Filippo Peritore A; Gugliandolo E; Fusco R; Crupi R; Impellizzeri D; Pozzebon M; Alfonsi D; Mattei N; Marcolongo G; Evangelista M; Cuzzocrea S; Di Paola R
FASEB J; 2020 Mar; 34(3):4085-4106. PubMed ID: 31950563
[TBL] [Abstract][Full Text] [Related]
20. Impaired Duodenal Palmitoylethanolamide Release Underlies Acid-Induced Mast Cell Activation in Functional Dyspepsia.
Sarnelli G; Pesce M; Seguella L; Lu J; Efficie E; Tack J; Elisa De Palma FD; D'Alessandro A; Esposito G
Cell Mol Gastroenterol Hepatol; 2021; 11(3):841-855. PubMed ID: 33065341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
